537 followers
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations. https://t.co/EnWvskUxNz https://t.co/4McEOTLY1I
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations. https://t.co/EnWvskUxNz https://t.co/4McEOTLY1I